SCHEMBL25859829

SCHEMBL25859829

Cc1ccc(S(=O)(=O)O[C@@H]2CCCOC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
CYP1A2 P05177 1/20 0.45
SLC12A2 P55011 1/20 0.39
SLC12A5 Q9H2X9 1/20 0.39
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 2/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
ACHE P22303 1/20 0.38
ENPP3 O14638 2/20 0.37
ENPP1 P22413 2/20 0.37
ENPP2 Q13822 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21488522 1.00 CYP2D6 (0.50) CYP2D6CYP1A2SLC12A2SLC12A5CYP3A4
SCHEMBL25173913 0.96 CYP2D6 (0.49) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL506784 0.91 CYP2D6 (0.52) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL507364 0.91 CYP2D6 (0.52) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL181292 0.91 CYP2D6 (0.52) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL4641154 0.88 CYP2D6 (0.51) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL181141 0.84 CYP2D6 (0.54) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
Fluoride SCHEMBL27871310 0.84 CYP2D6 (0.61) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL6198035 0.82 CYP2D6 (0.63) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL6198029 0.82 CYP2D6 (0.63) CYP2D6CYP1A2CYP3A4CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227470-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER VANDERBILT UNIVERSITY 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227470-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER KRAS, NRAS, TP53 CYP2D6 510/4885CYP1A2 1616/4885SLC12A2 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.